We previously reported the isolation of novel differentially expressed clones from substracted lymphocyte cDNA libraries of a pair of twins discordant for schizophrenia (Friedhoff et al., 1995). The clones were expressed in lymphocytes from the well twin but not in lymphocytes from the twin with schizophrenia. We investigated the expression of one of these novel clones, pOKSC12b (201 bp) in lymphocytes of subjects without psychiatric or other known illnesses, and subjects meeting DSM IV criteria for schizophrenia. Expression of 12 b was initially examined using Rnase Protection assay (Ambion). Sense and antisense RNA were transcribed with T7 or SP6 RNA polymerase in the presence of 32 Plabeled UTP. A calibration curve (50 attm-700 attm) was also constructed using sense RNA. Rnase protected 12 b fragments were analyzed by PAGE electrophoresis, followed by autoradiography. 12 b was found to be expressed in 25% of the normals, but 12 b could not be detected in lymphocytes of patients with schizophrenia. Competitive RT-PCR was also utilized. RNAs were reverse transcribed with MMLV reverse transcriptase and oligo-dT. PCR was performed with 12 b specific primers and the incorporation of 0.002-4.5 attmol of an internal standar and 32 PdATP. Following electrophoresis of the PCR products, the gel bands corresponding to the standard and 12 b were cut and cpms determined by scintillation counting. Detection of 12 b was significantly improved utilizing competitive RT-PCR. The 12 b transcript was present in 100% of the normal subjects analyzed. The expression in patients with schizophrenia is presently being analyzed. Partially supported by Harriet&Esteban Vicente. Evidence for etiologic heterogeneity in schizophrenia is relatively modest, despite the diversity of clinical manifestations. We have previously demonstrated that decreases in empirical recurrence risks stratified by birth order of the first affected child within sibships provides evidence of heterogeneity by segregation ratio (Zwaigenbaum, Szatmari and Jones, 1998). We have applied this analytic approach to a 1940-1969 birth cohort including all sibships with at least one individual diagnosed and treated for schizophrenia in Finland (N = 22985 families). The recurrence risk of schizophrenia. In these families is strongly related to birth order of the first affected child, decreasing steadily from 7.5% (95% C.I. =7.1-7.9%) when the first born is affected, to 2.2% (95% C.I. = 0.2-4.2%) when the first affected is 7th or later-born. Testing for incremental decreases in recurrence risk across these strata using isotonic regression reveals T' (a normal unit variate) = 5.45 (pϽ.00001). We further stratified the analysis by total sibship size, to separate heterogeneity effects from the potential confounding effects of reproductive stoppage rules. Birth order of the first affected child continues to be a strong predictor of recurrence risk in this modified analysis (T'=7.24). Moreover, this effect was observed even when the analysis was confined to multiplex families. Recurrence risk to later-born siblings in this subgroup (excluding the second affected child) is also dependent on the birth order of the first affected child (T'=3.73. pϽ.0001). These findings suggest that 1) schizophrenia is etiologically heterogeneous and that 2) there is etiologic heterogeneity even among familial cases. Saccadic eye-movements have been previously shown to be genetically determined and sensitive to alcohol. Data from 51 of an intended sample of 80 Caucasian and African American adult social drinkers performing two saccadic eye-movement tasks before and after an oral loading dose of alcohol were analyzed. They guided saccades (GS) task required subjects to follow unpredictable jumps in LED position in the horizontal plane; mean saccadic latency (L, msec) and peak saccadic velocity for an idealized 15-degree jump (V15m, deg/sec) were computed from 40 trials. The antisaccades (AS) task required subjects to inhibit the reflex to follow jumps and look in the opposite direction instead; L, V15, and the number of uninhibited reflexive saccades (RS) were computed for the AS task.
Evidence for etiologic heterogeneity in schizophrenia is relatively modest, despite the diversity of clinical manifestations. We have previously demonstrated that decreases in empirical recurrence risks stratified by birth order of the first affected child within sibships provides evidence of heterogeneity by segregation ratio (Zwaigenbaum, Szatmari and Jones, 1998) . We have applied this analytic approach to a 1940-1969 birth cohort including all sibships with at least one individual diagnosed and treated for schizophrenia in Finland (N = 22985 families). The recurrence risk of schizophrenia. In these families is strongly related to birth order of the first affected child, decreasing steadily from 7.5% (95% C.I. =7.1-7.9%) when the first born is affected, to 2.2% (95% C.I. = 0.2-4.2%) when the first affected is 7th or later-born. Testing for incremental decreases in recurrence risk across these strata using isotonic regression reveals T' (a normal unit variate) = 5.45 (pϽ.00001). We further stratified the analysis by total sibship size, to separate heterogeneity effects from the potential confounding effects of reproductive stoppage rules. Birth order of the first affected child continues to be a strong predictor of recurrence risk in this modified analysis (T'=7.24). Moreover, this effect was observed even when the analysis was confined to multiplex families. Recurrence risk to later-born siblings in this subgroup (excluding the second affected child) is also dependent on the birth order of the first affected child (T'=3.73. pϽ.0001). These findings suggest that 1) schizophrenia is etiologically heterogeneous and that 2) there is etiologic heterogeneity even among familial cases.
B. Substance Abuse Posters
48. INHIBITION Saccadic eye-movements have been previously shown to be genetically determined and sensitive to alcohol. Data from 51 of an intended sample of 80 Caucasian and African American adult social drinkers performing two saccadic eye-movement tasks before and after an oral loading dose of alcohol were analyzed. They guided saccades (GS) task required subjects to follow unpredictable jumps in LED position in the horizontal plane; mean saccadic latency (L, msec) and peak saccadic velocity for an idealized 15-degree jump (V15m, deg/sec) were computed from 40 trials. The antisaccades (AS) task required subjects to inhibit the reflex to follow jumps and look in the opposite direction instead; L, V15, and the number of uninhibited reflexive saccades (RS) were computed for the AS task.
At baseline, group differences were apparent only in the AS taks: African Americans were more deliberate in their eye-movements, showing longer L and greater V15, but no differences in RS, compared to Caucasians. A robust effect of alcohol was apparent in significant changes on both the ascending (69±12mg/dL) and descending (65±11mg/dL) limbs of the response; delayed L, slower V15 were apparent in both tasks, as were small but significant increases in RS in the AS task. RS was less sensitive to the low dose of alcohol in Caucasians (pϽ0.001). Thus, preliminary analysis of over half of the sample suggests a statistically significant association of the response to alcohol with ethnicity. Test-retest, placebo-control, and basic data collection in the remainder of the sample are under way, and must precede formal hypothesis testing. (Supported by AA02342). Alleles of the dopamine D2 receptor gene (DRD2) have in some case-control studies of European Americans (EAs) been associated to alcohol and/or drug dependence. There have also been numerous negative case-control studies, and a family-based study in alcoholics failed to show linkage disequilibrium (LD) with DRD2 alleles (Edenberg 1998). The present study examined LD of alcohol and/or drug (opiates and/or cocaine) dependence with three DRD2 polymorphisms: 1) the TaqI A system, 2) the TaqI D system, and 3) the functional-141CIns/Del promoter polymorphism. DNA samples were collected from small nuclear families (SNFs), where one or more offspring met DSM-III-R criteria for alcohol and/or drug dependence. There were 84 EA SNFs recruited, with 14 affected siblings of the probands, yielding a total of 98 potential transmissions. We found no evidence of LD with trait at any of the three polymorphic loci. The A1 allele was transmitted in 33 of 55 subjects with alcohol and/or drug dependence ( 2 tdt = 2.20, p = 0.14), in 27 of 44 subjects with alcohol dependence (with or without drug dependence) ( 2 tdt = 2.27, p = 0.13), and in 18 of 40 subjects with drug dependence (with or without alcohol dependence) ( 2 tdt = 0.40, p = 0.84). Similarly, no evidence of LD was obtained for the other two polymorphic systems. The results of this preliminary analysis do not provide evidence for LD between alcohol and/or drug dependence and alleles at any of the DRD2 loci studied. In a recent paper the author demonstrated that dexamethasone (DEX) induced inhibition of the acute opioid withdrawal in vitro (1). In this respect, since prostaglandins (PGs) have been reported to be involved in the expression of opiate withdrawal (2) and glucocorticoids control PGs biosynthesis by inhibiting the release of their common precursor, arachidonic acid through phospholipase A2 inhibitory proteins (3), it was suggested that DEX could reduce opiate withdrawal by blocking the release of the PGs precursor, arachidonic acid (1). Therefore, to verify whether the DEX-induced reduction of opiate withdrawal is related to the inhibition of PGs, in the present work the effect of cyclooxygenase (COX) inhibitors on morphine withdrawal was considered. Furthermore, although in a previous paper (2) it was reported that indomethacin, a well-known COX inhibitor, was able to reduce morphine withdrawal in vitro, we must remember that two isoform of COX exist: a constitutive (COX-1) form and an inducible (COX-2) form (4). COX-1 is constitutively expressed in most tissues and synthesizes PGs which regulate normal cell activity, whereas COX-2 is induced in a number of cells by pro-inflammatory stimuli (4). Therefore, in the present work we used tolmetin as a selective COX-1 inhibitor and meloxicam as a selective COX-2 inhibitor to verify whether the PGs involved in opiate withdrawal are produced by COX-1 and/or COX-2. All drugs were added before or after opiate agonists to verify whether they could act by preventing or reverting opiate dependence.
A FAMILY-BASED TDT

ANTAGONISM BY MELOXICAM OF
Opiate withdrawal was studied in vitro by using guinea pig ileum test: after a 4 min in vitro exposure to morphine a strong contracture of guinea pig isolated ileum was observed after the addition of naloxone. The results of this study indicates that both tolmetin (selective COX-1 inhibitor) and meloxicam (selective COX-2 inhibitor) treatment before or after morphine were able of both preventing and reversing the naloxone-induced contracture after exposure to the opioid agonist in a concentration-dependent fashion. It is of interest to note that meloxicam compared to tolmetin appeared to be more active in inhibiting morphine withdrawal. In fact, when meloxicam was added after morphine, the concentrations required to reduce morphine withdrawal were lower than those of tolmetin. These findings could be explained on the basis of the different pharmacological profile of the enzymes COX-1 and COX-2. In fact, COX-1 regulates normal cell activity whereas COX-2 is effectively absent from healthy tissues but its level rises dramatically during tissue damage. If we consider the opiate withdrawal to be a pathologic condition and morphine to be a noxious stimulus for the cell, the possibility that during dependence, morphine induces also the activation of the enzyme COX-2 should be considered. Therefore, COX-2 could represent the expression of pathologic conditions induced by morphine during the withdrawal phenomenon, and the strong activity of meloxicam supports this possibility. DEX has been reported to block the induction of COX-2 (4). Therefore, the present data suggest that DEX may inhibit PGs production during opiate withdrawal (1) also through the blockade of COX-2 activity.
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Dopaminergic abnormalities are implicated in the pathogenesis of substance abuse. Recently, two reports have been published suggesting an association between opioid dependence and presence of long alleles of the dopamine D 4 receptor (DRD4) gene exon III VNTR (Kotler et al. 1997; Li et al. 1997) . We have attempted to replicate this finding using a two-tired strategy employing independent case-control and family-based association samples. Our study was possibly the largest candidate gene association study to date on opioid dependence in a sample of 815 subjects, 396 of whom were patients. We found long alleles of the DRD4 exon III VNTR in similar frequency among 285 heroin addicts and 197 controls. Furthemore, no preferential transmission of long alleles to affected offspring was observed in a sample of 111 patients and their parents. Our results, therefore, do not support the hypothesis that alleles of the DRD4 exon III VNTR are susceptibility factors for opioid dependence in man. Several investigators have suggested a role for endogenous opioids in maternal-infant attachment behaviors. Additionally, social interaction has been found to stimulate enkephalin production. Also, while reduced enkephalin levels have been linked to a learned helplessness model of depression, administration of agents that inhibit the enkephalin degrading enzymes, neutral endopeptidase (NEP) and aminopeptidase, have been found to ameliorate symptoms of learned helplessness. Previous studies by the first author found that elevated plasma levels of neutral endopeptidase in children were associated with significantly increased social withdrawal and peer problems, reinforcing the view that degradation of enkephalins may be linked to a primary defect in the ability to either perceive or obtain reward from social interactions. In a further examination of this phenomenon we examined a dinucleotide repeat polymorphism at the gene encoding NEP, metallo-membrane endopeptidase (MME) in a sample of 126 non-Hispanic Caucasian college students assessed with the Parent Bonding Instrument, the NEO-Five Factor Personality Inventory, and the Symptom Checklist. A MANOVA was performed (Wilks: p Ͻ.05), revealing that the MME marker was associated with neuroticism (pϽ.002), negative affect (pϽ.001) and depression (pϽ.001). Additionally, the 'depressive' alleles were found to be associated on the Parent Bonding Instrument with significant reductions (pϽ.005) in several selfreported maternal care attributes, although it is not known whether this was reflective of real or perceived defects in maternal behavior. Alcoholism is a heterogenous, genetically mediated disorder. The contribution of genetics to alcoholism is known to vary across subtypes of alcoholics. One of the robust risk markers of vulnerability to alcoholism is the subjective response to ethanol in alcoholics. The study explored the EEG response to an acute dose of ethanol in two major sub-types of alcoholics. The sample included 20 individuals with alcohol dependence from the National Institute of Mental Health and NeuroSciences, Bangalore, India. The sample were categorized into high and low risk groups on the basis of family history of alcoholism and age of onset of dependence (Family History Positive-Early Onset [FHP-EO] and Family History Negative-Late Onset [FHN-LO] . Following 3 weeks of detoxification, each subject was given an acute dose of 95% ethanol (0.75 ml/kg body weight) mixed in five parts of water. EEG was recorded at baseline, 20 minutes and 60 minutes after consumption of ethanol. Spectral analysis of the EEG showed distinct patterns of response to ethanol in the two groups. The FHP-EO group showed early and prolonged relaxing effects (increased alpha 1 activity) while the FHP-LO group showed an initial relaxing effect followed by a early, prolonged activation effect (increased beta activity). The results highlight the contribution of family history and age of onset in mediating the response to alcohol and influencing vulnerability to alcoholism. As part of an international collaborative study (WHO-ISBRA), we collected clinical data and biological samples from 600 residents of Montréal, stratified by age, gender and alcohol consumption (abstinent individuals, light or heavy drinkers, alcoholics). Alcoholics were recruited from inpatient treatment facilities and met criteria for DSM-IIIR and DSM-IV alcohol dependence. Among heavy and light drinkers, 32% and 18% respectively, met criteria for a lifetime diagnosis of DSM-IIIR alcohol dependence. The clinical battery included items subsuming a number of diagnostic interview schedules (eg., SCID, DIS), and also included extensive information regarding patterns of alcohol use, levels of impairment and distress and family history of substance abuse and other psychiatric disorders. A 3-cluster solution accounted for 76% of the variance in these data. Cluster 1, which comprised 18% of the population, was characterized by poor self-regulation, an increased incidence of binge drinking, disinterest in reducing drug abuse or seeking help, and failure to meet social or legal obligations. Cluster 2 (29% of the population) showed heavy and consistent alcohol consumption with little evidence of impairment of work or social relationships and a low level of perceived distress regarding alcohol consumption. Cluster 3 (53% of the population) reported severe levels of dysfunction in work and social relationships. a strong desire to reduce alcohol consumption and to seek help and greater levels of guilt, distress and perseveration around the topic of alcohol abuse. Comorbid diagnoses were frequent in all clusters, but patterns of comorbidity varied significantly between clusters. These phenotypes map imperfectly on conventional typologies of alcohol and drug abuse.
OPIOIDS AND ATTACHMENT BEHAVIOR
DIFFERENTIAL EEG RESPONSE TO
TOWARD AN EXTENDED PHENOTYPE OF ALCO
Supported Recent studies on the genetics of alcoholism have examined the association between alcoholism and the dopamine D2 receptor locus (DRD2); our previous studies of Chinese Han gave negative results. One of explanations for the contradictory results is that DRD2 is only linked to some particular subtypes of alcoholism. The recent family study has demonstrated two transmissible forms of alcoholism: a pure form that is neither linked to anxiety nor depression and a form that is associated with anxiety disorders. In a double-blind study, bromocriptine, a DRD2 agonist, or placebo was administered to alcoholics with either the A1 or only the A2 allele of DRD2 gene. The greatest improvement in craving and anxiety occurred in the bromocriptine-treated A1 alcoholics. Therefore, we hypothesize that DRD2 may be associated with a predisposing to anxious alcoholism.
We recruited 126 Han alcoholics from hospital and 98 Han controls from community. The 126 alcoholics were interviewed using Chinese Version of Modified SADS-L to obtain their lifetime psychiatric diagnoses and then divided into two groups: 24 alcoholics with primary anxiety and 102 alcoholics without primary anxiety.
The results showed that both genotypes and alleles at TagI A and TagI B had significant differences in frequencies between anxious alcoholics and controls. Moreover, there was a significant association between the haplotypes for the TagI A and TagI B and anxious alcoholics. These results suggest that a predisposing to anxious alcoholism may be linked to DRD2.
ASSOCIATION STUDIES WITH SSR MARKERS AT KNOWN PHYSICAL DISTANCES FROM THE ALDH2 LOCUS IN ALCOHOLIC AND CONTROL JAPANESE GROUPS. Koch H, McClay J, Loh, E-W, Higuchi S 2
, Ball, D and Craig IW. SGDP Research Centre, Institute of Psychiatry and Neurosciences Department, King's Healthcare, Denmark Hill, London, UK and Kurihama National Hospital, Kanagawa, Japan 2 . We have investigated the association of microsatellite markers in close physical proximity to the RFLP in exon 12 of the aldehyde dehydrogenase locus, ALDH2 (chromosome 12p23) and separated from it by known distances (50 kb to 500 kb). This range is presumed to embrace loci with alleles that will be in some degree of linkage disequilibrium. We have employed existing markers supplemented with novel SSRs -identified by sequence analysis of overlapping BACs (http:sequence. aecom.yu.edu/chr12/) in an analysis of control and alcoholic populations (for which the frequencies of low activity ALDH2 alleles were 0.26 and 0.0, respectively). Allele image patterns for pooled samples (65 individuals) have been generated and examined for significant differences -as described previously (Hill et al 1999 Neuroreport 10, 843-848) and the results compared with information derived from individual genotyping. We have additionally developed an allele specific genotyping assay for the RFLP allowing analysis with the ABI377 or 310 machines and have validated this by retyping the pools. The following markers were used for investigating potential association of alleles at flanking loci following individual genotyping cen -HK(di)1-D12S2263-ALDH2*-D12S1344-D12S821-qter.
Of these, D12S839 (p = 0.06); D12S1344 (p = 0.002); D12S2263 (p = 0.05) and D12S821 (p = 0.09) gave directional allele differences between the original alcoholic and control pools. The validity of the results will be tested by individual genotyping in independent replication pools. These data provide insights into the parameters important in selecting markers for genome association scans, the success of which appears to have a major dependence on the mutational stability of the marker employed.
SUBSTANCE ABUSE IN BIPOLAR DISORDER. Law
, Meyer E, Hu K, DePaulo R, Gershon E, Reisch T, Nurnberger J. Roudebush VAMC 1 and Indiana University School of Medicine 2 . Prevalence studies have shown that bipolar affective disorder often co-occurs with alcohol and substance abuse. Large scale prevalence studies such as the Epidemiological Catchment Area study showed that bipolar affective disorder is more often associated with substance abuse then any other DSM Axis 1 disorder. In view of the high heritability of bipolar affective disorder, the Bipolar Genetics Project examined the relationship between substance abuse and families with multiple cases of bipolar disorders. Affected subjects (bipolar I or II, schizoaffective disorder, and major recurrent depression) had significantly earlier reported onset of illness if they had alcohol dependence (Mean age of onset = 20.1±9.8) or other substance abuse disorders (18.5±7.4) then those with no substance or alcohol dependence (22.7±10.7, pϽ.0001). Other demographic and phenomenological differences between these groups will be presented. The relationship between onset of substance abuse and of affective disorder will also be discussed. We examined four polymorphisms in the (opioid receptor gene in 231 Chinese heroin addicts from Sichuan Province, SW China and compared the allele and genotype frequencies to those in 185 normal controls from the same geographic region. Two of these polymorphisms (Ala6Val and Ser 147Cys) were not polymorphic in the Chinese, with only Ala6 and Ser147 observed. The frequencies of the two other polymorphisms were significantly different from those observed in Caucasians, African Americans and Native Americans. The Asn40Asp and IVS2+691G/G polymorphisms did not differ significantly for allele (P = 0.16; P = 0.21) genotype (P = 0.32; P = 0.09), or haplotype frequencies (P = 0.24) between the heroin-addicted cases and normal controls. This indicates that the (opioid receptor is not likely to be a major genetic risk factor in this population. This study examines the relationship between Attention Deficit Hyperactivity Disorder (ADHD) and psychoactive substance use. Subjects were 257 adult parents ascertained through a family-genetics study of children and adolescent sibling pairs with ADHD. Adult subjects were assessed for lifetime psychiatric diagnoses with the SADS-LAR supplemented by the Behavioral Disorders Module of the K-SADS-PL. Blood was obtained for genotyping. We used a logistic regression model to evaluate 8 potential risk factors for their role in the development of substance use, including Gender, Ethnicity, SES, ADHD, Conduct Disorder, and polymorphisms of the dopamine transporter (DAT1) and two dopamine receptor (DRD4, DRD2) genes. Subjects numbered 130 females and 127 males. Approximately 34% met lifetime criteria for ADHD and 12% for Conduct Disorder. Nicotine Use was found in 48%, Alcohol Abuse/Dependence in 25%, Marijuana Abuse/ Dependence in 17%, and Cocaine Abuse/Dependence in 11%. Nicotine Use was predicted by ADHD, Conduct Disorder, and a DNA variant at DRD2 (X 2 =23.940, p=0.0001, DF=3). Lifetime Substance Dependence was predicted by Conduct Disorder and a DNA variant at DRD4 (X 2 =42.150, p=0.0001, DF=2). All variables of specific substance abuse or dependence were strongly influenced by Gender and history of Conduct Disorder. Findings support prior observations of developmental pathways from ADHD to Conduct Disorder to Substance Dependence. Our findings are novel by potentially adding support for the additive risk of particular genotypes contributing to psychoactive substance use. Possible associations between DNA polymorphisms and substance use disorders require further study and could lead to additional strategies for prevention and treatment.
ASSOCIATION ANALYSIS OF POLYMORPHISMS IN THE MU OPIOID RECEPTOR GENE AND HEROIN
SUBSTANCE ABUSE/DEPENDENCE
FUNCTIONAL AND STRUCTURAL POLYMOR-PHISMS IN THE DOPAMINE D2 RECEPTOR GENE: NO ASSOCIATION WITH SUBTYPES OF ALCOHOLISM.
Parsian A; Cloninger CR; Zhang ZH. Washington University School of Medicine, St. Louis, MO 63110, U.S.A. Dopaminergic pathway genes are considered as candidate genes for several neuropsychiatric diseases including severe alcoholism. Since 1990, there have been numerous reports of conflicting association studies of Taq I-A allele of the dopamine D2 receptor (DRD2) gene with alcoholism. Functional and structural variations in the candidate genes offer more direct evaluation of their role in the development of a disorder. To determine the role of such polymorphisms in the DRD2 gene in the development of subtypes of alcoholism, we screened a sample of 173 alcoholics, 29 proband-parent trios, and 88 normal controls with the A-241G and -141C Ins/Del in the promoter region and C311G in exon 7 of the DRD2 gene. Comparisons of total alcoholics with normal controls for allele frequency differences of these three polymorphisms were negative. Allele frequency differences of the two functional polymorphisms in the promoter region between type II alcoholics, alcoholics with medical complications and normal controls were not significant. The results of the TDT analyses for functional polymorphisms were also negative. There was significant linkage disequilibrium only between −141 Ins/Del and Taq I D polymorphisms. We conclude that the functional and structural variations in DRD2 gene do not play a major role in the development of alcoholism subtypes in our sample.
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. HUMAN Long et al., (1998) reported the genetic linkage to alcohol dependence on chromosomes 4 and 11 from an autosome-wide scan in an American Indian population. The best evidence for linkage was with markers D11S1984 (Lod=3.1, nominal p=0.00007) on short arm of chromosome 11, in close proximity to the dopamine D4 receptor (DRD4) and tyrosine hydroxylase (TH) genes, and D4S3242 on short arm of chromosome 4 (Lod=2.8, nominal p=0.0002) near the B1 GABA receptor gene (GABRB1). To determine the role of genes in the chromosomal regions 11p15 and 4p12 in the development of alcohol dependence, a sample of alcoholics (n=133) and normal controls (n=88) were screened with the DRD4, TH, and GABRB1 gene polymorphisms Comparison of total alcoholics with normal controls for GABRB1 was highly significant (p=0.004). The difference between type II alcoholics and normal controls for the same allele frequencies was also significant (p=0.029). The allele distributions of the polymorphisms in the DRD4 and TH genes in alcoholics and normal controls were similar and their differences were not significant. Our association studies indicate that the GABRB1 gene may play a role in the development of alcoholism. However, our results with TH and DRD4 genes indicate that these genes may not play a major role in the development of alcoholism. Alcoholism and depression frequently co-occur, but the causes of this comorbidity remains uncertain. On explanation is that major depression and alcoholism represent alternative manifestations of the same underlying vulnerability (i.e., a depressive spectrum), and there are sex-specific factors which influence clinical presentation. Alternatively, depression and alcoholism may have separate etiologies, but the presence of one disorder increases the risk for developing the other.
62.
We address these issues using data on 9,200 adult twins from the population-based Virginia Twin Registry Subjects were assessed for lifetime major depression (MD), alcohol dependence (AD), and alcohol abuse/dependence (AAD) by structured interview. MZ cotwins of men and women with MD were at significantly increased risk for alcohol disorders, while the associations for DZ cotwins varied with diagnostic definition. Results from structural modeling analyses conducted with the entire sample (Ͼ4,000 pairs) suggest that the comorbidity of alcoholism and depression is due primarily to individual-specific environmental factors, with a modest contribution of shared genetic sources within the sexes, but no overlap across sexes. However, when analyses were limited to subjects aged 40 and older (who had completed more of the risk period for developing MD and AD) we found some support for the depression spectrum hypothesis. Among opposite-sex pairs over 40, the correlation in liability for male AD with female MD was significantly greater than zero and similar in magnitude to the AD-MD correlation among MZ pairs. These results suggest that depression and alcoholism have overlapping liability with clinical presentations modified by sex-specific factors.
HAPLOTYPES AT THE DRD2 LOCUS AND SEVERE
ALCOHOLISM. Noble EP, Zhang X, Ritchie T, Sparkes RS. University of California, Los Angeles.
Association studies of the minor Taq1 A allele of the D2 dopamine receptor (DRD2) gene with alcoholism have produced conflicting findings. Failure to assess alcoholics . Data from 1,091 children of alcohol pedigree and control families taken from the COGA study show that offspring of alcoholic parents are more prone to behavior disorders than are children of non-alcoholic parents. Alcohol pedigree families refer to those in which the proband was ascertained through an alcohol treatment center. A few control families contained alcoholics, but they were removed from the following analyses. The behavior disorders predominated in the offspring, with the proportion of affected offspring increasing with the number of alcoholic parents (i.e. 0 affected parents, 1 affected parent, and 2 affected parents), depression among these youth also increased in relation to the number of alcoholic parents. Because of recent studies looking at mixed states of behavior and mood (comorbidity), we looked at Oppositional Defiant Disorder, and Conduct Disorder in these children, a) to see if either one or both were co-morbid with depression, and b) to examine the relationship of these comorbid disorders to parental alcoholism. Both of these disorders in offspring were comorbid with depression. Results showed both ODD and CD predicted adult alcoholism independently of one another. However, ODD that was co-morbid with depression, predicted adult alcohol status (increasing with the number of alcoholic parents). On the other hand, CD, on its own, without ODD and without depression predicted parental alcohol status (increasing with the number of alcoholic parents). There are few studies of genetic influences on alcohol and cigarette consumption in randomly ascertained families. In this study, we estimated the heritabilities of alcohol and cigarette use, and the additive genetic and random environmental correlations between alcohol and cigarette consumption, using data from white adult participants in the Fels Longitudinal Study, a community-based epidemiological study. Annual number of drinks consumed was derived from questionnaires for 557 individuals (268 males and 289 females; age range 18-92 years; average age 36 years) from 123 nuclear and extended families. These data included non-drinkers, but excluded ex-drinkers. Using a maximum likelihood method for pedigree data, a significant heritability (± SE) of 0.29 ± 0.10 was obtained for square root-transformed annual number of drinks consumed. Excluding ex-smokers, but retaining non-smokers, annual cigarette consumption was derived for 527 of these individuals. The heritability estimate of 0.41 ± 0.09 obtained for cigarette consumption was significant. Bivariate analyses of these data yielded low additive genetic and random environmental correlations of 0.28 ± 0.22 and 0.17 ± 0.13, respectively, between alcohol and cigarette consumption. In sum, these results show that both alcohol and cigarette consumption in randomly sampled families are moderately heritable, but that alcohol and cigarette consumption may only to a small degree be influenced by the same genetic and environmental factors.
QUANTITATIVE GENETICS OF ALCOHOL
C. Miscellaneous Other Disorders: Posters
Eating Disorders
IMPLICATIONS OF TWIN STUDIES OF EATING
DISORDERS. Bulik C. Virginia Institute for Psychiatric and Behavioral Genetics, Virginia Commonwealth University, Richmond, VA 23298. Twin studies have enhanced our understanding of the genetic and environmental contribution to the etiology of eating disorders. Studies from Virginia support a substantial contribution of additive genetic effects to liability to bulimia nervosa. Heritability estimates based on single occasions of measurement were approximately 55%; however, a subsequent model using diagnostic information from two interview waves, thereby controlling for measurement error, estimated heritability to be 83% with the remaining variance attributable to unique environmental effects, and shared environment having no contribution.
Australian twin studies have evaluated continuous measures of dietary restraint, and concern about eating, weight, and shape. Wade and colleagues found a substantial contribution of genetic factors to the etiology of these factors (up to 68% of the variance attributed to additive genetic effects) with the exception being "weight concern" which was best accounted for by a combination of shared environmental and unique environmental effects (c 2 =52%).
Twin studies from Minnesota explored developmental effects in eating disorders by studying 11 and 17 year old twins' responses to the Eating Disorders Inventory. Whereas a 2 was estimated to be 0.35-0.60 for the older twins with no contribution from shared environment, heritability estimates for the younger twins ranged from 0.04-0.49 with substantial contributions of shared environment for most subscales. Shared environment may play a greater role pre-pubertally, and genetic effects on
